BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
OSG
Octave Specialty Group, Inc.
There isn't enough reported data to score OSG yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
OSG Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
OSG's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like OSG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
OSG PE Valuation
OSG has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 11x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
OSG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect OSG to return to profit, with revenue growing.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over OSG on earnings quality, reporting a profit while its opponent remains loss making.
OSG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.48 | — |
| Q3 2026 | -$1.59 | +$14.92 |
| Q2 2026 | -$3.63 | +$11.16 |
| Q1 2026 | -$4.84 | +$8.43 |
| Q4 2025 | -$5.93 | +$5.69 |
| Q3 2025 | -$16.51 | -$16.08 |
| Q2 2025 | -$14.79 | -1019% |
| Q1 2025 | -$13.27 | -1090% |
| Q4 2024 | -$11.62 | -6556% |
OSG is still losing money, but far less than before: $1.59 per share over the past year, against $16.51 at its worst in late 2025.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over OSG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over OSG on profitability, with a higher operating margin.
OSG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.3M | +28% |
| Q2 2026 | $83M | +51% |
| Q1 2026 | $104.2M | +66% |
| Q3 2025 | $66.6M | -42% |
| Q2 2025 | $55M | -48% |
| Q1 2025 | $62.8M | -39% |
| Q3 2024 | $114M | +54% |
| Q2 2024 | $105M | +69% |
OSG's revenue is recovering but still below its 2022 peak: $85M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +33 points |
| Q2 2026 | -14% | +28 points |
| Q1 2026 | -3.2% | +21 points |
| Q4 2025 | -46% | N/A |
| Q3 2025 | -48% | -25 points |
| Q2 2025 | -42% | -44 points |
| Q1 2025 | -24% | -49 points |
| Q3 2024 | -24% | -116 points |
OSG's operating margin was −16% last quarter, up 32 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with OSG at down 101%.
OSG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$10.2M | -576% |
| Q1 2026 | -$10.1M | +$2.5M |
| Q4 2025 | -$666K | +$26.6M |
| Q1 2025 | -$12.6M | -170% |
| Q4 2024 | -$27.2M | -131% |
| Q1 2024 | $18M | -77% |
| Q4 2023 | $88M | -93% |
| Q3 2023 | $11M | -77% |
OSG's free cash flow was −$2M over the past year, against −$20M the year before. Free cash flow isn't a meaningful measure for financial services companies like OSG.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
OSG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +28.8K shares |
| 1 year | -5.6% | -2.7M shares |
| 3 years | -3% | -1.4M shares |
| 5 years | -3.5% | -1.6M shares |
| Available history | -0.3% | -158K shares |
OSG has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2024 | $11.7M |
| Q1 2020 | $3M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
OSG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 20.4x | High |
| Q2 2024 | 4.2x | High |
| Q1 2024 | 4.7x | High |
| Q4 2023 | 11.7x | High |
| Q3 2023 | 2.0x | Moderate |
| Q2 2023 | 0.9x | Very low |
| Q1 2023 | 0.9x | Very low |
| Q4 2022 | 1.1x | Healthy |
OSG's net debt is more than 20 years of its operating earnings (EBITDA), up from 2.0 years a year ago. Net leverage isn't a meaningful measure for financial services companies like OSG.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
OSG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.2 | Neutral |
| Stochastic | 59.9 | Neutral |
OSG's weekly RSI is 49 (neutral) and its Stochastic is 60 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
OSG PE vs Financial Services Sector
| Metric | OSG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
OSG has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
OSG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.74 | 7.4% above |
| 20 week MA | $5.04 | 1% above |
| 50 week MA | $5.52 | 7.8% below |
| 100 week MA | $7.22 | 30% below |
| 200 week MA | $10.7 | 52% below |
OSG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over OSG on returns for 2026, with the stronger performance.
OSG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.6 | $16.7 | -23% |
| 2021 | $16.7 | $15.5 | -7.4% |
| 2022 | $15.5 | $16.7 | +7.6% |
| 2023 | $16.7 | $16.5 | -1% |
| 2024 | $16.5 | $12.3 | -25% |
| 2025 | $12.3 | $8.00 | -35% |
| 2026 YTD | $8.00 | $5.09 | -36% |
OSG has finished three years in a row lower, and it's down 36% so far in 2026.